Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	68.40	-10.94	-34.61
Graham Fair Price	17.80	12.10	10.27
PEG	-56.18	0.22	-0.51
Price/Book	18.16	1.02	0.86
Price/Cash Flow	-88.73	11.57	-102.67
Prices/Earnings	-9.41	7.87	8.68
Price/Sales	33.25	5.19	3.90
Price/FCF	-88.73	11.57	-102.67
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	7.54	1.13	1.05
Operating Margin	198.62	0.89	0.30
ROA	26.97	< 0.005	< 0.005
ROE	0.02	0.03	30.43
ROIC	0.03	0.07	115.68
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	1.56	-0.75	107.75
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.98	1.74	77.97
EPS QOQ	-0.17	0.35	106.72
FCF QOQ	-1.23	11.83	862.42
Revenue QOQ	0.14	-0.08	-39.63
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.22	0.44	98.16
Quick Ratio	2.18	2.08	-4.49
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13.76	14.20	3.14
Cash	8.88	19.95	124.66
Capex	-0.09	-0.05	39.82
Free Cash Flow	-0.12	1.25	981.11
Revenue	3.04	2.78	-8.54
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.77	2.08	-24.81
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.95	-3.79	-28.66
Naive Interpretation	Member

06 - Financial Health · Bad

Rating